MAP Pharmaceuticals, Inc. (MAPP) Tops Q2 EPS by 10c
Tweet
Share
E-mailGet Alerts MAPP Hot Sheet
Price: $28.11 --0%
Financial Fact:
Net income (loss): -12.62M
Today's EPS Names:
YRD, CAG, CALM, More
Financial Fact:
Net income (loss): -12.62M
Today's EPS Names:
YRD, CAG, CALM, More
Join SI Premium – FREE
MAP Pharmaceuticals, Inc. (NASDAQ: MAPP) reported Q2 loss of ($0.28), $0.10 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $3.5 million versus the consensus estimate of $2.55 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron Technology (MU) Tops Q4 EPS by $2.26, Offers Guidance
- Jefferies Financial Group (JEF) Tops Q3 EPS by 8c
- AAR Corp. (AIR) Tops Q1 EPS by 18c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
